McKenna Mark C. 4
4 · NewAmsterdam Pharma Co N.V. · Filed Jul 19, 2024
Insider Transaction Report
Form 4
McKenna Mark C.
Director
Transactions
- Award
Option (right to buy)
2024-07-17+72,500→ 72,500 totalExercise: $18.81Exp: 2034-07-17→ Ordinary Shares (72,500 underlying)
Footnotes (1)
- [F1]33% of the shares underlying the option will vest on July 17, 2025, the one-year anniversay of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for two years, subject to the Reporting Person's continued service through each such date.